Guangzhou Improve Med Instrument (SHE:300030) — Market Cap & Net Worth
Market Cap & Net Worth: Guangzhou Improve Med Instrument (300030)
Guangzhou Improve Med Instrument (SHE:300030) has a market capitalization of $289.56 Million (CN¥1.98 Billion) as of June 17, 2026. Listed on the SHE stock exchange, this China-based company holds position #15150 globally and #4495 in its home market, demonstrating a -5.19% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou Improve Med Instrument's stock price CN¥6.40 by its total outstanding shares 309187315 (309.19 Million). Review Guangzhou Improve Med Instrument balance sheet liabilities to assess the company's total debt and financial obligations.
Guangzhou Improve Med Instrument Market Cap History: 2015 to 2026
Guangzhou Improve Med Instrument's market capitalization history from 2015 to 2026. Data shows change from $872.97 Million to $289.56 Million (-10.42% CAGR).
Guangzhou Improve Med Instrument Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou Improve Med Instrument's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.68x
Guangzhou Improve Med Instrument's market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.92x
Guangzhou Improve Med Instrument's market cap is 22.92 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $618.26 Million | $517.10 Million | $30.48 Million | 1.20x | 20.29x |
| 2017 | $381.32 Million | $549.65 Million | $11.16 Million | 0.69x | 34.17x |
| 2018 | $231.04 Million | $549.96 Million | -$136.80 Million | 0.42x | N/A |
| 2019 | $319.87 Million | $575.06 Million | $26.02 Million | 0.56x | 12.29x |
| 2020 | $551.81 Million | $919.23 Million | $162.52 Million | 0.60x | 3.40x |
| 2021 | $479.15 Million | $799.83 Million | $18.57 Million | 0.60x | 25.80x |
| 2022 | $311.73 Million | $710.77 Million | -$198.30 Million | 0.44x | N/A |
| 2023 | $350.64 Million | $644.62 Million | -$63.20 Million | 0.54x | N/A |
| 2024 | $249.75 Million | $581.33 Million | -$117.90 Million | 0.43x | N/A |
| 2025 | $332.99 Million | $486.26 Million | $14.53 Million | 0.68x | 22.92x |
Competitor Companies of 300030 by Market Capitalization
Companies near Guangzhou Improve Med Instrument in the global market cap rankings as of June 17, 2026.
Key companies related to Guangzhou Improve Med Instrument by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #162 globally with a market cap of $147.53 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #255 globally with a market cap of $99.63 Billion USD ( €85.22 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #346 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #541 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Intuitive Surgical Inc | NASDAQ:ISRG | $147.53 Billion | $416.55 |
| #255 | EssilorLuxottica S. A. | PA:EL | $99.63 Billion | €184.05 |
| #346 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €93.00 |
| #541 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Guangzhou Improve Med Instrument Historical Marketcap From 2015 to 2026
Between 2015 and today, Guangzhou Improve Med Instrument's market cap moved from $872.97 Million to $ 289.56 Million, with a yearly change of -10.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥289.56 Million | -13.04% |
| 2025 | CN¥332.99 Million | +33.33% |
| 2024 | CN¥249.75 Million | -28.77% |
| 2023 | CN¥350.64 Million | +12.48% |
| 2022 | CN¥311.73 Million | -34.94% |
| 2021 | CN¥479.15 Million | -13.17% |
| 2020 | CN¥551.81 Million | +72.51% |
| 2019 | CN¥319.87 Million | +38.45% |
| 2018 | CN¥231.04 Million | -39.41% |
| 2017 | CN¥381.32 Million | -38.32% |
| 2016 | CN¥618.26 Million | -29.18% |
| 2015 | CN¥872.97 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Guangzhou Improve Med Instrument was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $289.56 Million USD |
| MoneyControl | $289.56 Million USD |
| MarketWatch | $289.56 Million USD |
| marketcap.company | $289.56 Million USD |
| Reuters | $289.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more